Clinical Trial Update: Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pentostatin and rituximab in patients with low-grade non-Hodgkin lymphoma or chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Pentostatin (pentostatin)
• Rituximab (rituximab)

Snippet

Sponsor: Pharmatech Oncology | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED